Top Vaccines companies in Switzerland by Return on Equity (ROE)
Switzerland
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
161.93%
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
| 2 |
1.06%
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 3 |
-7.26%
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 4 |
-13.49%
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 5 |
-33.76%
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 6 |
-35.13%
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 7 |
-104.48%
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Return on Equity (ROE) ?
The Vaccines company in Switzerland with the highest Return on Equity (ROE) is ADC Therapeutics SA (NYSE: ADCT) at 161.93%.
-
Which Vaccines company in Switzerland has the lowest Return on Equity (ROE) ?
The Vaccines company in Switzerland with the lowest Return on Equity (ROE) is Basilea Pharmaceutica AG (Swiss Stock Exchange: BSLN.SW) at -104.48%.
-
What are the top 10 Vaccines companies in Switzerland by Return on Equity (ROE) ?
The top 10 Vaccines companies in Switzerland by Return on Equity (ROE) are ADC Therapeutics SA, Sandoz Group AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, AC Immune SA, Molecular Partners AG and Basilea Pharmaceutica AG.
-
What are the bottom 10 Vaccines companies in Switzerland by Return on Equity (ROE) ?
The bottom 10 Vaccines companies in Switzerland by Return on Equity (ROE) are Basilea Pharmaceutica AG, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, MoonLake Immunotherapeutics, Sandoz Group AG and ADC Therapeutics SA.
